Abstract
Summary
Marijuana intoxication is the euphoria, relaxation, and sometimes undesirable side effects that can occur when people use marijuana. The ability to perform complex tasks may be adversely affected. Many users report excessive appetite after marijuana use.Toxicity associated with synthetic cannabinoids can be more severe, requiring more aggressive treatment. Agitation or acute psychosis should be treated with benzodiazepines or, if necessary, antipsychotic agents, such as haloperidol or olanzapine.
LPI (LP Information)' newest research report, the “Cannabinoid Intoxication Treatment Drug Industry Forecast” looks at past sales and reviews total world Cannabinoid Intoxication Treatment Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Cannabinoid Intoxication Treatment Drug sales for 2023 through 2029. With Cannabinoid Intoxication Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabinoid Intoxication Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Cannabinoid Intoxication Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cannabinoid Intoxication Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cannabinoid Intoxication Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabinoid Intoxication Treatment Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabinoid Intoxication Treatment Drug.
The global Cannabinoid Intoxication Treatment Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cannabinoid Intoxication Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cannabinoid Intoxication Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cannabinoid Intoxication Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cannabinoid Intoxication Treatment Drug players cover Oregon Poison Center, Indiana Poison Center, MedVet, Mill Creek Animal Hospital and VCA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cannabinoid Intoxication Treatment Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Benzodiazepines
Haloperidol
Olanzapine
Others
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Oregon Poison Center
Indiana Poison Center
MedVet
Mill Creek Animal Hospital
VCA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cannabinoid Intoxication Treatment Drug market?
What factors are driving Cannabinoid Intoxication Treatment Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cannabinoid Intoxication Treatment Drug market opportunities vary by end market size?
How does Cannabinoid Intoxication Treatment Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Cannabinoid Intoxication Treatment Drug Industry Forecast” looks at past sales and reviews total world Cannabinoid Intoxication Treatment Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Cannabinoid Intoxication Treatment Drug sales for 2023 through 2029. With Cannabinoid Intoxication Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabinoid Intoxication Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Cannabinoid Intoxication Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cannabinoid Intoxication Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cannabinoid Intoxication Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabinoid Intoxication Treatment Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabinoid Intoxication Treatment Drug.
The global Cannabinoid Intoxication Treatment Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cannabinoid Intoxication Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cannabinoid Intoxication Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cannabinoid Intoxication Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cannabinoid Intoxication Treatment Drug players cover Oregon Poison Center, Indiana Poison Center, MedVet, Mill Creek Animal Hospital and VCA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cannabinoid Intoxication Treatment Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Benzodiazepines
Haloperidol
Olanzapine
Others
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Oregon Poison Center
Indiana Poison Center
MedVet
Mill Creek Animal Hospital
VCA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cannabinoid Intoxication Treatment Drug market?
What factors are driving Cannabinoid Intoxication Treatment Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cannabinoid Intoxication Treatment Drug market opportunities vary by end market size?
How does Cannabinoid Intoxication Treatment Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cannabinoid Intoxication Treatment Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cannabinoid Intoxication Treatment Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cannabinoid Intoxication Treatment Drug by Country/Region, 2018, 2022 & 2029
2.2 Cannabinoid Intoxication Treatment Drug Segment by Type
2.2.1 Benzodiazepines
2.2.2 Haloperidol
2.2.3 Olanzapine
2.2.4 Others
2.3 Cannabinoid Intoxication Treatment Drug Sales by Type
2.3.1 Global Cannabinoid Intoxication Treatment Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Cannabinoid Intoxication Treatment Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cannabinoid Intoxication Treatment Drug Sale Price by Type (2018-2023)
2.4 Cannabinoid Intoxication Treatment Drug Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Cannabinoid Intoxication Treatment Drug Sales by Application
2.5.1 Global Cannabinoid Intoxication Treatment Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Cannabinoid Intoxication Treatment Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cannabinoid Intoxication Treatment Drug Sale Price by Application (2018-2023)
3 Global Cannabinoid Intoxication Treatment Drug by Company
3.1 Global Cannabinoid Intoxication Treatment Drug Breakdown Data by Company
3.1.1 Global Cannabinoid Intoxication Treatment Drug Annual Sales by Company (2018-2023)
3.1.2 Global Cannabinoid Intoxication Treatment Drug Sales Market Share by Company (2018-2023)
3.2 Global Cannabinoid Intoxication Treatment Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Cannabinoid Intoxication Treatment Drug Revenue by Company (2018-2023)
3.2.2 Global Cannabinoid Intoxication Treatment Drug Revenue Market Share by Company (2018-2023)
3.3 Global Cannabinoid Intoxication Treatment Drug Sale Price by Company
3.4 Key Manufacturers Cannabinoid Intoxication Treatment Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cannabinoid Intoxication Treatment Drug Product Location Distribution
3.4.2 Players Cannabinoid Intoxication Treatment Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cannabinoid Intoxication Treatment Drug by Geographic Region
4.1 World Historic Cannabinoid Intoxication Treatment Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Cannabinoid Intoxication Treatment Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cannabinoid Intoxication Treatment Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cannabinoid Intoxication Treatment Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Cannabinoid Intoxication Treatment Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cannabinoid Intoxication Treatment Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cannabinoid Intoxication Treatment Drug Sales Growth
4.4 APAC Cannabinoid Intoxication Treatment Drug Sales Growth
4.5 Europe Cannabinoid Intoxication Treatment Drug Sales Growth
4.6 Middle East & Africa Cannabinoid Intoxication Treatment Drug Sales Growth
5 Americas
5.1 Americas Cannabinoid Intoxication Treatment Drug Sales by Country
5.1.1 Americas Cannabinoid Intoxication Treatment Drug Sales by Country (2018-2023)
5.1.2 Americas Cannabinoid Intoxication Treatment Drug Revenue by Country (2018-2023)
5.2 Americas Cannabinoid Intoxication Treatment Drug Sales by Type
5.3 Americas Cannabinoid Intoxication Treatment Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cannabinoid Intoxication Treatment Drug Sales by Region
6.1.1 APAC Cannabinoid Intoxication Treatment Drug Sales by Region (2018-2023)
6.1.2 APAC Cannabinoid Intoxication Treatment Drug Revenue by Region (2018-2023)
6.2 APAC Cannabinoid Intoxication Treatment Drug Sales by Type
6.3 APAC Cannabinoid Intoxication Treatment Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cannabinoid Intoxication Treatment Drug by Country
7.1.1 Europe Cannabinoid Intoxication Treatment Drug Sales by Country (2018-2023)
7.1.2 Europe Cannabinoid Intoxication Treatment Drug Revenue by Country (2018-2023)
7.2 Europe Cannabinoid Intoxication Treatment Drug Sales by Type
7.3 Europe Cannabinoid Intoxication Treatment Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cannabinoid Intoxication Treatment Drug by Country
8.1.1 Middle East & Africa Cannabinoid Intoxication Treatment Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cannabinoid Intoxication Treatment Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Cannabinoid Intoxication Treatment Drug Sales by Type
8.3 Middle East & Africa Cannabinoid Intoxication Treatment Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cannabinoid Intoxication Treatment Drug
10.3 Manufacturing Process Analysis of Cannabinoid Intoxication Treatment Drug
10.4 Industry Chain Structure of Cannabinoid Intoxication Treatment Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cannabinoid Intoxication Treatment Drug Distributors
11.3 Cannabinoid Intoxication Treatment Drug Customer
12 World Forecast Review for Cannabinoid Intoxication Treatment Drug by Geographic Region
12.1 Global Cannabinoid Intoxication Treatment Drug Market Size Forecast by Region
12.1.1 Global Cannabinoid Intoxication Treatment Drug Forecast by Region (2024-2029)
12.1.2 Global Cannabinoid Intoxication Treatment Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cannabinoid Intoxication Treatment Drug Forecast by Type
12.7 Global Cannabinoid Intoxication Treatment Drug Forecast by Application
13 Key Players Analysis
13.1 Oregon Poison Center
13.1.1 Oregon Poison Center Company Information
13.1.2 Oregon Poison Center Cannabinoid Intoxication Treatment Drug Product Portfolios and Specifications
13.1.3 Oregon Poison Center Cannabinoid Intoxication Treatment Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Oregon Poison Center Main Business Overview
13.1.5 Oregon Poison Center Latest Developments
13.2 Indiana Poison Center
13.2.1 Indiana Poison Center Company Information
13.2.2 Indiana Poison Center Cannabinoid Intoxication Treatment Drug Product Portfolios and Specifications
13.2.3 Indiana Poison Center Cannabinoid Intoxication Treatment Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Indiana Poison Center Main Business Overview
13.2.5 Indiana Poison Center Latest Developments
13.3 MedVet
13.3.1 MedVet Company Information
13.3.2 MedVet Cannabinoid Intoxication Treatment Drug Product Portfolios and Specifications
13.3.3 MedVet Cannabinoid Intoxication Treatment Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 MedVet Main Business Overview
13.3.5 MedVet Latest Developments
13.4 Mill Creek Animal Hospital
13.4.1 Mill Creek Animal Hospital Company Information
13.4.2 Mill Creek Animal Hospital Cannabinoid Intoxication Treatment Drug Product Portfolios and Specifications
13.4.3 Mill Creek Animal Hospital Cannabinoid Intoxication Treatment Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mill Creek Animal Hospital Main Business Overview
13.4.5 Mill Creek Animal Hospital Latest Developments
13.5 VCA
13.5.1 VCA Company Information
13.5.2 VCA Cannabinoid Intoxication Treatment Drug Product Portfolios and Specifications
13.5.3 VCA Cannabinoid Intoxication Treatment Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 VCA Main Business Overview
13.5.5 VCA Latest Developments
14 Research Findings and Conclusion